Tag: DSM

Learnings from the Earnings – Who’s Up? Who’s Down?

Learnings from the Earnings – Who’s Up? Who’s Down?

March 23, 2019 |

The lucky 13 – with spring comes a sense of renewal and this season these lucky 13 bioeconomy bellwethers recently shared their 2018 and Q4 earnings to reveal uncertainties with trade wars, especially between the U.S. and China, some deals that fell through impacting losses, and pricing issues. But all is not lost as there […]

Read More

Proud papa DSM transfers Biosuccinium to Roquette, dissolves Reverdia JV

Proud papa DSM transfers Biosuccinium to Roquette, dissolves Reverdia JV

February 23, 2019 |

In the Netherlands, there is a big change coming for bio-succinic acid production, a graduation of sorts for Biosuccinium. Since 2012, Reverdia’s parent companies — Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and Roquette, a global leader in plant-based ingredients for Food, Nutrition and Health markets, — have been producing […]

Read More

In for a Penny, In for a Pound: The Advanced Bioeconomy and all the pivots

In for a Penny, In for a Pound: The Advanced Bioeconomy and all the pivots

December 28, 2017 |

It’s been such a busy cycle in the bioeconomy that we are well overdue for a shout-out to a pal of the Digest, Henry Threadgill, for winning a Pulitzer Prize for his landmark composition, In for a Penny, In for a Pound. Threadgill’s masterpiece (which you can experience here) comes to mind as news arrives […]

Read More

Fuels America leaders say “thank you, President Trump” for RFS support

Fuels America leaders say “thank you, President Trump” for RFS support

November 10, 2017 |

In Washington, a coalition of the nation’s leaders in advanced and cellulosic biofuels thanked President Trump for his commitment to the RFS, which “has attracted billions of dollars of investment in first-of-a-kind technologies in the advanced and cellulosic biofuels industry.” They also express concerns about the EPA’s July proposal to reduce White House-approved growth in […]

Read More

Amyris enters first production development and production agreement with DSM

Amyris enters first production development and production agreement with DSM

July 17, 2017 |

In California, Amyris announce it has entered into its first product development and production agreement with Koninklijke DSM N.V. (Royal DSM), the global science-based company active in health, nutrition and materials, to develop a food and nutrition molecule for which DSM is a major market provider. As part of the previously announced equity investment DSM […]

Read More

DSM invests $25 million in Amyris

DSM invests $25 million in Amyris

May 8, 2017 |

In California, Amyris, Inc. the industrial bioscience company, and Koninklijke DSM N.V., the global science-based company active in health, nutrition and materials, announced that they have agreed for DSM to make an equity investment in Amyris. At the same time, the companies will enter into a development cooperation focused on products for the global health […]

Read More

Strategic Intent: The Digest’s 2017 Multi-Slide Guide to DSM in the advanced bioeconomy

Strategic Intent: The Digest’s 2017 Multi-Slide Guide to DSM in the advanced bioeconomy

May 8, 2017 |

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences, DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such […]

Read More

DSM invests in Amyris

DSM invests in Amyris

May 8, 2017 |

In California, DSM led a round of investors that will put up to $95 million in equity financing into Amyris via a registered direct offering of convertible preferred stock, and private placements of convertible preferred stock and warrants. Amyris is in the process of reducing its debt by approximately $75 million. DSM has agreed to […]

Read More

Strategic Intent: The Digest’s 2016 Multi-Slide Guide to DSM in the advanced bioeconomy

Strategic Intent: The Digest’s 2016 Multi-Slide Guide to DSM in the advanced bioeconomy

September 1, 2016 |

This season, The Digest is hosting the Strategic Intent webinar series, looking at the plans, progress and future milestones of strategic stakeholders in the Advanced Bioeconomy. In this slide deck, we looked at DSM and its direct investments, partnerships and alliances with companies both heralded and unknown.

Read More

Consolidation! Dyadic sells industrial technology biz to DuPont for $75M

Consolidation! Dyadic sells industrial technology biz to DuPont for $75M

November 11, 2015 |

As Dyadic cashes out of industrial biotech and retains a C1 license for pharma, DSM and Syngenta also announce a partnership. Companies are girding their loins for the long haul. The Digest takes a look, In Florida, DuPont Industrial Biosciences will acquire substantially all of the enzyme and technology assets Dyadic’s Industrial Technology business for $75 […]

Read More